279 related articles for article (PubMed ID: 33198125)
21. Increased apoptosis is associated with robust immune cell infiltration and cytolytic activity in breast cancer.
Murthy V; Oshi M; Tokumaru Y; Endo I; Takabe K
Am J Cancer Res; 2021; 11(7):3674-3687. PubMed ID: 34354867
[TBL] [Abstract][Full Text] [Related]
22. Dendritic cell infiltration and prognosis of early stage breast cancer.
Treilleux I; Blay JY; Bendriss-Vermare N; Ray-Coquard I; Bachelot T; Guastalla JP; Bremond A; Goddard S; Pin JJ; Barthelemy-Dubois C; Lebecque S
Clin Cancer Res; 2004 Nov; 10(22):7466-74. PubMed ID: 15569976
[TBL] [Abstract][Full Text] [Related]
23. Significance of Tumor-Infiltrating Lymphocytes and the Expression of Topoisomerase IIα in the Prediction of the Clinical Outcome of Patients with Triple-Negative Breast Cancer after Taxane-Anthracycline-Based Neoadjuvant Chemotherapy.
Rao N; Qiu J; Wu J; Zeng H; Su F; Qiu K; Wu J; Yao H
Chemotherapy; 2017; 62(4):246-255. PubMed ID: 28472798
[TBL] [Abstract][Full Text] [Related]
24. Adenovirus efficiently transduces plasmacytoid dendritic cells resulting in TLR9-dependent maturation and IFN-alpha production.
Basner-Tschakarjan E; Gaffal E; O'Keeffe M; Tormo D; Limmer A; Wagner H; Hochrein H; Tüting T
J Gene Med; 2006 Nov; 8(11):1300-6. PubMed ID: 16952196
[TBL] [Abstract][Full Text] [Related]
25. Immune cytolytic activity is associated with reduced intra-tumoral genetic heterogeneity and with better clinical outcomes in triple negative breast cancer.
Oshi M; Kawaguchi T; Yan L; Peng X; Qi Q; Tian W; Schulze A; McDonald KA; Narayanan S; Young J; Liu S; Morris LG; Chan TA; Kalinski P; Matsuyama R; Otsuji E; Endo I; Takabe K
Am J Cancer Res; 2021; 11(7):3628-3644. PubMed ID: 34354864
[TBL] [Abstract][Full Text] [Related]
26. Differential production of inflammatory chemokines by murine dendritic cell subsets.
Proietto AI; O'Keeffe M; Gartlan K; Wright MD; Shortman K; Wu L; Lahoud MH
Immunobiology; 2004; 209(1-2):163-72. PubMed ID: 15481150
[TBL] [Abstract][Full Text] [Related]
27. A Novel Three-Gene Score as a Predictive Biomarker for Pathologically Complete Response after Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer.
Oshi M; Angarita FA; Tokumaru Y; Yan L; Matsuyama R; Endo I; Takabe K
Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34065619
[TBL] [Abstract][Full Text] [Related]
28. ITPKC as a Prognostic and Predictive Biomarker of Neoadjuvant Chemotherapy for Triple Negative Breast Cancer.
Oshi M; Newman S; Murthy V; Tokumaru Y; Yan L; Matsuyama R; Endo I; Takabe K
Cancers (Basel); 2020 Sep; 12(10):. PubMed ID: 32992708
[TBL] [Abstract][Full Text] [Related]
29. In vivo conversion of BM plasmacytoid DC into CD11b+ conventional DC during virus infection.
Liou LY; Blasius AL; Welch MJ; Colonna M; Oldstone MB; Zuniga EI
Eur J Immunol; 2008 Dec; 38(12):3388-94. PubMed ID: 18979509
[TBL] [Abstract][Full Text] [Related]
30. The chemokine receptor CCR2 maintains plasmacytoid dendritic cell homeostasis.
Cédile O; Jørgensen LØ; Frank I; Wlodarczyk A; Owens T
Immunol Lett; 2017 Dec; 192():72-78. PubMed ID: 29106985
[TBL] [Abstract][Full Text] [Related]
31. Conflicting roles of
Oshi M; Gandhi S; Tokumaru Y; Yan L; Yamada A; Matsuyama R; Ishikawa T; Endo I; Takabe K
Am J Cancer Res; 2021; 11(10):5094-5110. PubMed ID: 34765314
[TBL] [Abstract][Full Text] [Related]
32. MxA expression is associated with tumor-infiltrating lymphocytes and is a prognostic factor in triple-negative breast cancer.
Kim YA; Lee HJ; Heo SH; Park HS; Park SY; Bang W; Song IH; Park IA; Gong G
Breast Cancer Res Treat; 2016 Apr; 156(3):597-606. PubMed ID: 27075916
[TBL] [Abstract][Full Text] [Related]
33. IRF family proteins and type I interferon induction in dendritic cells.
Tailor P; Tamura T; Ozato K
Cell Res; 2006 Feb; 16(2):134-40. PubMed ID: 16474425
[TBL] [Abstract][Full Text] [Related]
34. Characterization of conventional and plasmacytoid dendritic cells in swine secondary lymphoid organs and blood.
Jamin A; Gorin S; Le Potier MF; Kuntz-Simon G
Vet Immunol Immunopathol; 2006 Dec; 114(3-4):224-37. PubMed ID: 16978709
[TBL] [Abstract][Full Text] [Related]
35. Cytotoxic T-lymphocyte infiltration and chemokine predict long-term patient survival independently of tumor mutational burden in triple-negative breast cancer.
Katsuta E; Yan L; Opyrchal M; Kalinski P; Takabe K
Ther Adv Med Oncol; 2021; 13():17588359211006680. PubMed ID: 33868461
[TBL] [Abstract][Full Text] [Related]
36. New Biomarkers Based on Dendritic Cells for Breast Cancer Treatment and Prognosis Diagnosis.
Zhao F; Yan F; Liu H
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835467
[TBL] [Abstract][Full Text] [Related]
37. Transcriptome-Based Network Analysis Unveils Eight Immune-Related Genes as Molecular Signatures in the Immunomodulatory Subtype of Triple-Negative Breast Cancer.
Zhang J; Wang L; Xu X; Li X; Guan W; Meng T; Xu G
Front Oncol; 2020; 10():1787. PubMed ID: 33042828
[No Abstract] [Full Text] [Related]
38. MELK expression in breast cancer is associated with infiltration of immune cell and pathological compete response (pCR) after neoadjuvant chemotherapy.
Oshi M; Gandhi S; Huyser MR; Tokumaru Y; Yan L; Yamada A; Matsuyama R; Endo I; Takabe K
Am J Cancer Res; 2021; 11(9):4421-4437. PubMed ID: 34659896
[TBL] [Abstract][Full Text] [Related]
39. Immune Profiles of Tumor Microenvironment and Clinical Prognosis among Women with Triple-Negative Breast Cancer.
Deng L; Lu D; Bai Y; Wang Y; Bu H; Zheng H
Cancer Epidemiol Biomarkers Prev; 2019 Dec; 28(12):1977-1985. PubMed ID: 31533938
[TBL] [Abstract][Full Text] [Related]
40. Interplay between plasmacytoid dendritic cells and tumor-specific T cells in peripheral blood influences long-term survival in non-small cell lung carcinoma.
Laheurte C; Seffar E; Gravelin E; Lecuelle J; Renaudin A; Boullerot L; Malfroy M; Marguier A; Lecoester B; Gaugler B; Saas P; Truntzer C; Ghiringhelli F; Adotevi O
Cancer Immunol Immunother; 2023 Mar; 72(3):579-589. PubMed ID: 35989364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
